XSHG
603360
Market cap3.17bUSD
Dec 05, Last price
31.70CNY
1D
-1.12%
1Q
28.91%
IPO
493.63%
Name
Dalian BIO-CHEM Co Ltd
Chart & Performance
P/E
64.84
P/S
17.07
EPS
0.49
Div Yield, %
2.65%
Shrs. gr., 5y
6.77%
Rev. gr., 5y
8.51%
Revenues
1.31b
+23.09%
Net income
345m
+5.14%
CFO
163m
-58.18%
Dividend
May 31, 20240.84 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Dalian BIO-CHEM Company Limited produces and sells bactericides, antiseptics, and fungicides for various industrial applications in Europe, North and South Americas, the Middle East, Africa, and Asia. The company's products are used as disinfection; algaecide in water treatment, such as petrochemicals, electricity, central air conditioning, and industrial cooling water; anti-corrosion in emulsions, mineral slurries, pigment dispersions, adhesives, tackifiers, metalworking fluids, and cosmetics aqueous system; and aqueous system of leather, paint and coating, textile, and dyeing. Its products also used for anti-mildew and anti-algae applications, as well as manufactures dry film preservative, which is used for paints and coatings. Dalian BIO-CHEM Company Limited was founded in 2003 and is based in Dalian, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||